Search research articles
Contact Us
Filters
Showing results (21-30 of 213) with videos related to
Page
of 22
Sort By:
European Urology
|
October 11, 2016
Reply to Che-Kai Tsao, Matthew D. Galsky, and William K. Oh's Platinum Opinion. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: Urgent Need To Minimize The Risk Of Neutropenic Fever. Eur Urol 2016;70:707-708
Matthew R Sydes, Alastair W S Ritchie, Nicholas D James, et al.
Trials
|
January 11, 2020
Monitoring in practice - How are UK academic clinical trials monitored? A survey
Sharon B Love, Victoria Yorke-Edwards, Sarah Lensen, et al.
Lancet (London, England)
|
May 2, 2021
Postoperative radiotherapy in prostate cancer - Authors' reply
Christopher C Parker, Paul Sargos, Matthew R Sydes, et al.
European Urology
|
July 25, 2016
Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform
Silke Gillessen, Clare Gilson, Nick James, et al.
Trials
|
June 9, 2007
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, et al.
Trials
|
February 11, 2014
Response to: Practical methods for incorporating summary time-to-event data into meta. Authors' reply
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, et al.
Trials
|
November 8, 2024
A new trial monitoring plan (TMP) template for clinical trials: output from a Delphi process
Shiva Taheri, Victoria Yorke-Edwards, Matthew R Sydes, et al.
Clinical Trials (London, England)
|
November 1, 2019
A third trial oversight committee: Functions, benefits and issues
J Athene Lane, Carrol Gamble, William J Cragg, et al.
Clinical Trials (London, England)
|
January 11, 2022
Protecting blinded trials in electronic hospital systems
Matthew R Sydes, Wai Keong Wong, Ameet Bakhai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 26, 2010
A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity
Sarah L Gulliford, Mike Partridge, Matthew R Sydes, et al.
Page
of 22
Search research articles
Search
Showing results (21-30 of 213) with videos related to
Sort By:
Page
of 22
European Urology
|
October 11, 2016
Reply to Che-Kai Tsao, Matthew D. Galsky, and William K. Oh's Platinum Opinion. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: Urgent Need To Minimize The Risk Of Neutropenic Fever. Eur Urol 2016;70:707-708
Matthew R Sydes, Alastair W S Ritchie, Nicholas D James, et al.
Trials
|
January 11, 2020
Monitoring in practice - How are UK academic clinical trials monitored? A survey
Sharon B Love, Victoria Yorke-Edwards, Sarah Lensen, et al.
Lancet (London, England)
|
May 2, 2021
Postoperative radiotherapy in prostate cancer - Authors' reply
Christopher C Parker, Paul Sargos, Matthew R Sydes, et al.
European Urology
|
July 25, 2016
Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform
Silke Gillessen, Clare Gilson, Nick James, et al.
Trials
|
June 9, 2007
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, et al.
Trials
|
February 11, 2014
Response to: Practical methods for incorporating summary time-to-event data into meta. Authors' reply
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, et al.
Trials
|
November 8, 2024
A new trial monitoring plan (TMP) template for clinical trials: output from a Delphi process
Shiva Taheri, Victoria Yorke-Edwards, Matthew R Sydes, et al.
Clinical Trials (London, England)
|
November 1, 2019
A third trial oversight committee: Functions, benefits and issues
J Athene Lane, Carrol Gamble, William J Cragg, et al.
Clinical Trials (London, England)
|
January 11, 2022
Protecting blinded trials in electronic hospital systems
Matthew R Sydes, Wai Keong Wong, Ameet Bakhai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 26, 2010
A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity
Sarah L Gulliford, Mike Partridge, Matthew R Sydes, et al.
Page
of 22